Are sulfonylureas passé?

Author: FeinglosMark N, GreenJennifer B

Paper Details 
Original Abstract of the Article :
Sulfonylureas and similarly acting rapid insulin secretagogues have long been available to manage type 2 diabetes. These agents have a well understood mechanism of action and are in large part well tolerated. However, sulfonylurea therapy is unlikely to sustain adequate long-term glycemic control an...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1007/s11892-006-0008-9

データ提供:米国国立医学図書館(NLM)

Sulfonylureas: Still Relevant in the Management of Type 2 Diabetes?

Type 2 diabetes, a chronic disease characterized by high blood sugar levels, affects millions worldwide. This research examines the role of sulfonylureas, a class of medications that have long been used to manage type 2 diabetes, and discusses their potential benefits and limitations in the context of newer treatment options.

Evaluating Sulfonylureas: Benefits and Limitations

The review acknowledges the well-understood mechanism of action and generally good tolerability of sulfonylureas. However, the authors highlight the limitations of these drugs, including their potential for long-term glycemic control, side effects such as hypoglycemia and weight gain, and potential adverse effects on ischemic preconditioning and cardiac outcomes.

Navigating Diabetes Management: Sulfonylureas in Combination Therapy

The review concludes that while sulfonylureas can be effective as part of combination therapy for diabetes management, newer agents are often preferred due to their improved safety profile and potential for long-term glycemic control.

Dr.Camel's Conclusion

The journey through the desert of type 2 diabetes requires the right tools for the trek. While sulfonylureas have long been a reliable companion, newer medications offer potential advantages for managing this challenging condition. Choosing the appropriate treatment approach should be based on individual patient factors and a comprehensive understanding of the benefits and limitations of different medications.

Date :
  1. Date Completed 2007-02-26
  2. Date Revised 2019-11-10
Further Info :

Pubmed ID

17076998

DOI: Digital Object Identifier

10.1007/s11892-006-0008-9

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.